SENSEX    73738.45       89.83    |    NIFTY    22368       31.60 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
Bhel at centrestage after robust Q2 result
14-Nov-19   08:31 Hrs IST

Bharat Heavy Electricals (Bhel) reported 40.74% rise in consolidated net profit to Rs 121.70 crore on 8.18% fall in total income to Rs 6367.03 crore in Q2 September 2019 over Q2 September 2018.

Bharti Airtel, Grasim Industries, Vedanta and ONGC will unveil their quarterly results today, 14 November 2019.

Indiabulls Housing Finance said that the company has made timely payment of interest / principal (as the case may be) in respect of Secured Redeemable Non- Convertible Debentures (NCDs) issued by company, on private placement basis.

Aurobindo Pharma said that the United States Food and Drug Administration (US FDA) inspected company's Unit IV, a general injectable formulation manufacturing facility situated at Pashamylaram, Hyderabad, from 4 to 13 November 2019. At the end of the inspection, the company was issued a 'Form 483' with 14 observations. None of these observations are related to data integrity issues. The company will respond to the US FDA within the stipulated timeline.

Cadila Healthcare reported 74.32% fall in consolidated net profit to Rs 107.20 crore on 13.43% rise in total income to Rs 3393.50 crore in Q2 September 2019 over Q2 September 2018.

Blue Star reported 94.07% rise in consolidated net profit to Rs 37.94 crore on 21.5% rise in total income to Rs 1260.07 crore in Q2 September 2019 over Q2 September 2018.

Bata India reported 29.97% rise in consolidated net profit to Rs 71.30 crore on 7.53% rise in total income to Rs 739.67 crore in Q2 September 2019 over Q2 September 2018.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.86 88.89 1.07
United Kingdom (GBP) 1.16 1.00 103.18 1.24
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.94 0.81 83.42 1.00
Market News << ALL News
  23-Apr-2024, (04:00 )  NBCC rallies as new ..
  23-Apr-2024, (03:27 )  Artson Engineering h..
  23-Apr-2024, (03:25 )  Aarti Drugs Baddi fa..
  23-Apr-2024, (03:19 )  Mastek jumps on majo..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)